Clinical trials sponsored by The Methodist Hospital Research Institute

Phase breakdown

Conditions studied

Recruiting trials led by The Methodist Hospital Research Institute

• 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
  NCT06887218 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CBD for Pain Following Orthopedic Shoulder Surgery
  NCT06381791 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
  NCT06339320 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
  NCT01913106 · Phase: Phase 1, Phase 2 · Ages: No age limits stated · Sex: Male · 1 location
• Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
  NCT07651319 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 86 Years · Sex: All (male and female) · 1 location
• Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
  NCT07182279 · Phase: Phase 1, Phase 2 · Ages: 40 Years and older · Sex: Male · 1 location
• Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
  NCT06072703 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Ocrelizumab for Psychosis by Autoimmunity
  NCT03971487 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 35 Years · Sex: All (male and female) · 1 location
• Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer
  NCT06833866 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
  NCT03541928 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Prehabilitation for Kidney Transplant Candidates
  NCT06886256 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · 1 location
• Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
  NCT05582200 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Stem Cells for Erectile Dysfunction Post RALP
  NCT07048314 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: Male · 1 location
• Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
  NCT07042685 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
  NCT07383649 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is The Methodist Hospital Research Institute recruiting for?

The Methodist Hospital Research Institute is the lead sponsor of 15 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.